{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9049593", "DateCompleted": {"Year": "1997", "Month": "05", "Day": "05"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0949-2321", "JournalIssue": {"Volume": "2", "Issue": "1", "PubDate": {"Year": "1997", "Month": "Jan"}}, "Title": "European journal of medical research", "ISOAbbreviation": "Eur J Med Res"}, "ArticleTitle": "Effects of Boswellia serrata gum resin in patients with ulcerative colitis.", "Pagination": {"StartPage": "37", "EndPage": "43", "MedlinePgn": "37-43"}, "Abstract": {"AbstractText": ["Ulcerative colitis is a chronic inflammatory disease of the colon where leukotrienes are suggested to play an important role for keeping inflammation active. Boswellic acids, the biologically active ingredients of the gum resin of Boswellia serrata (Sallai guggal), have been shown to be specific, nonredox and noncompetitive inhibitors of 5-lipoxygenase, the key enzyme of leukotriene biosynthesis. In patients suffering from ulcerative colitis grade II and III the effect of Boswellia serrata gum resin preparation (350 mg thrice daily for 6 weeks) on stool properties, histolopathology and scan microscopy of rectal biopsies, blood parameters including Hb, serum iron, calcium, phosphorus, proteins, total leukocytes and eosinophils was studied. Patients receiving sulfasalazine (1 g thrice daily) served as controls. All parameters tested improved after treatment with Boswellia serrata gum resin, the results being similar compared to controls: 82% out of treated patients went into remission; in case of sulfasalazine remission rate was 75%."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Govt. Medical College, Jammu, J&K, India."}], "LastName": "Gupta", "ForeName": "I", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Parihar", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Malhotra", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Singh", "ForeName": "G B", "Initials": "GB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "L\u00fcdtke", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Safayhi", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ammon", "ForeName": "H P", "Initials": "HP"}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Controlled Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Eur J Med Res", "NlmUniqueID": "9517857", "ISSNLinking": "0949-2321"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Gastrointestinal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Hemoglobins"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphates"}, {"RegistryNumber": "3XC8GUZ6CB", "NameOfSubstance": "Sulfasalazine"}, {"RegistryNumber": "E1UOL152H7", "NameOfSubstance": "Iron"}, {"RegistryNumber": "SY7Q814VUP", "NameOfSubstance": "Calcium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Abdominal Pain"}, {"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Biopsy"}, {"QualifierName": ["analysis"], "DescriptorName": "Blood Proteins"}, {"QualifierName": [], "DescriptorName": "Body Weight"}, {"QualifierName": ["blood"], "DescriptorName": "Calcium"}, {"QualifierName": [], "DescriptorName": "Child"}, {"QualifierName": ["drug therapy", "pathology", "physiopathology"], "DescriptorName": "Colitis, Ulcerative"}, {"QualifierName": [], "DescriptorName": "Diarrhea"}, {"QualifierName": [], "DescriptorName": "Feces"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Gastrointestinal Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hemoglobins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Iron"}, {"QualifierName": [], "DescriptorName": "Leukocyte Count"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Odds Ratio"}, {"QualifierName": ["blood"], "DescriptorName": "Phosphates"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pathology"], "DescriptorName": "Rectum"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sulfasalazine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1997", "Month": "1", "Day": "1"}, {"Year": "1997", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1997", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9049593"]}}]}